CHAMPIONS ONCOLOGY, INC.

Q: Jul 31 2026

FY: Apr 30 2026

Q: Jan 31 2026

Q: Oct 31 2025

Q: Jul 31 2025

FY: Apr 30 2025

Q: Jan 31 2025

Q: Oct 31 2024

Q: Jul 31 2024

FY: Apr 30 2024

Q: Jan 31 2024

Q: Oct 31 2023

Q: Jul 31 2023

FY: Apr 30 2023

Q: Jan 31 2023

Q: Oct 31 2022

Q: Jul 31 2022

FY: Apr 30 2022

Q: Jan 31 2022

Q: Oct 31 2021

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Financial Statements and Exhibits

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

5.02

2.02,9.01

2.02,9.01

2.02,9.01

2.02,9.01

5.07

5.02,9.01

2.02,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Registration of Securities on Exchange

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

06b

06b

06

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Rule 506

06

06

06

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

No description available

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

No description available

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Required Information in Proxy Statement

Definitive Proxy Statement

Brainin Robert Lawrence

Brainin Robert Lawrence

Brainin Robert Lawrence

ACKERMAN JOEL

Breitfeld Philip P.

SIDRANSKY DAVID

Mendelson Daniel Newman

TOBIN SCOTT R

ACKERMAN JOEL

Breitfeld Philip P.

TOCQUEVILLE ASSET MANAGEMENT L.P.

SIDRANSKY DAVID

Breitfeld Philip P.

ACKERMAN JOEL

TOBIN SCOTT R

Mendelson Daniel Newman

West Elk Partners, LP

ACKERMAN JOEL

none

Davis Brady

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Definitive information statement

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

No description available

Letter from the SEC

Letter from the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Definitive information statement